TLPH
Talphera Inc
NASDAQ · Pharmaceuticals
$0.81
+0.03 (+3.21%)
Open$0.78
Previous Close$0.79
Day High$0.84
Day Low$0.76
52W High$31.89
52W Low$18.17
Volume—
Avg Volume57.0K
Market Cap37.95M
P/E Ratio—
EPS$-1.52
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+3,109.3% upside
Current
$0.81
$0.81
Target
$26.13
$26.13
$16.33
$26.13 avg
$37.99
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 15.18M | 15.27M | 16.61M |
| Net Income | 3.38M | 4.70M | 4.66M |
| Profit Margin | 22.3% | 30.8% | 28.0% |
| EBITDA | 5.75M | 6.30M | 6.21M |
| Free Cash Flow | 2.69M | 4.04M | 4.00M |
| Rev Growth | +21.2% | -3.4% | +2.7% |
| Debt/Equity | 0.41 | 0.36 | 0.39 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |